QuadMedicine, Inc. (KOSDAQ:464490)
South Korea · Delayed Price · Currency is KRW 4,445.00
+5.00 (0.11%)
At close: Sep 23, 2026
QuadMedicine Market Cap
QuadMedicine has a market cap or net worth of 51.04 billion as of September 25, 2026.
Market Cap
51.04B
Enterprise Value
41.78B
Revenue
7.14B
Ranking
n/a
PE Ratio
n/a
Stock Price
4,445.00
ChartMarket Cap Chart
Since December 12, 2025, QuadMedicine's market cap has decreased from 199.95B to 51.04B, a decrease of -74.47%. That is a compound annual growth rate of -82.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 23, 2026 | 51.04B | -71.13% |
| Dec 30, 2025 | 176.81B | -11.57% |
| Dec 12, 2025 | 199.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ABION | 60.91B |
| Psomagen | 59.73B |
| NovMetaPharma | 59.46B |
| TegoScience | 58.21B |
| J2KBIO | 53.86B |
| CHOOLIP & SCIENCES | 53.68B |
| KoBioLabs | 50.68B |
| ADBiotech | 48.05B |